Patent details

EP2391893 Title: LYOPHILISED DABIGATRAN

Basic Information

Publication number:
EP2391893
PCT Application Number:
PCT/EP/2010/050925
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP107016701
PCT Publication Number:
WO/2010/086329
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LYOPHILISED DABIGATRAN
French Title of Invention:
Dabigatran lyophilisé
German Title of Invention:
LYOPHILISIERTES DABIGATRAN
SPC Number:

Dates

Filing date:
27/01/2010
Grant date:
03/09/2014
EP Publication Date:
03/09/2014
PCT Publication Date:
05/08/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/12/2011
EP B1 Publication Date:
03/09/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/01/2015
Expiration date:
27/01/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/01/2010
 
 

Name:
Boehringer Ingelheim International GmbH
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

Name:
STANGIER Joachim
Address:
Germany (DE)

Priority

Priority Number:
09151865
Priority Date:
02/02/2009
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 9/19;
Filing date Document type Number of pages